NCT07225894Completed
PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pilot Phase
Designing an Ethnodrama Addressing PrEP Stigma Toward Young Cisgender Women in Kenya
Source: ClinicalTrials.gov · Last updated 4 Aug 2026
Brief summary (registry, in English)
The investigators will pilot test an ethnodrama intervention designed to transform community member beliefs about and foster support of young cisgender women (YCW) using Pre-exposure Prophylaxis (PrEP).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 144 (actual)
- First submitted
- 28 Oct 2025
- Start date
- 1 Dec 2025
- Primary completion date
- 17 Mar 2026
- Lead sponsor
- Duke University
- Diseases
- HIV
- NCT number
- NCT07225894
What you commit to
- Study type: Interventional
- Participants enrolled: 144
- From 1 Dec 2025 to the primary completion date, 17 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Inclusion:
- Young women who are currently using or have previously used PrEP
- Community members (adult women and men) who will be identified from the audience during the first play in a round
- Adult audience members (female and male) who heard about the play from the public announcements and chose to attend and watch the play
- Exclusion:
- N/A
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Impact Research and Development Coordinator of this site? Confirm its status | Kisumu | Kenya | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.